Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist

Tetrahedron Letters

Volumn 51, Issue 38, 2010, Pages 5020-5023

  Ross, Nicolette C ^a   Kulkarni, Santosh S ^a   McLaughlin, Jay P ^b   Aldrich, Jane V ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cyclic tetrapeptide; Cyclization; Molecular modeling

Indexed keywords

CJ 15 208; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYCLIZATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR MODEL; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN CONFORMATION;

EID: 78549290623     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.07.086     Document Type: Article

References (31)

1. Metcalf, M. D.; Coop, A. AAPS J. 2005, 7, E704-E722;
2. Aldrich, J. V.; McLaughlin, J. P. AAPS J. 2009, 11, 312-322.
3. Aldrich, J. V.; Vigil-Cruz, S. C.. In Burger's Medicinal Chemistry & Drug Discovery; Abraham, D. J., Ed.; John Wiley & Sons: New York, 2003; Vol. 6, pp 329-481.
4. Aldrich, J. V.; Patkar, K. A.; McLaughlin, J. P. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 18396-18401.
5. Gilon, C.; Halle, D.; Chorev, M.; Selinger, Z.; Byk, G. Biopolymers 1991, 31, 745-750.
6. Closse, A.; Huguenin, R. Helv. Chim. Acta 1974, 57, 533-545;
7. Itazaki, H.; Nagashima, K.; Sugita, K.; Yoshida, H.; Kawamura, Y.; Yasuda, Y.; Matsumoto, K.; Ishii, K.; Uotani, N.; Nakai, H.; Terui, A.; Yoshimatsu, S.; Ikenishi, Y.; Nakagawa, Y. J. Antibiot. (Tokyo) 1990, 43, 1524-1532;
8. Singh, S. B.; Zink, D. L.; Polishook, J. D.; Dombrowski, A. W.; Darkin-Rattray, S. J.; Schmatz, D. M.; Goetz, M. A. Tetrahedron Lett. 1996, 37, 8077-8080;
9. Mori, H.; Urano, Y.; Kinoshita, T.; Yoshimura, S.; Takase, S.; Hino, M. J. Antibiot. (Tokyo) 2003, 56, 181-185.
10. Saito, T.; Hirai, H.; Kim, Y. J.; Kojima, Y.; Matsunaga, Y.; Nishida, H.; Sakakibara, T.; Suga, O.; Sujaku, T.; Kojima, N. J. Antibiot. (Tokyo) 2002, 55, 847-854.
11. Seale, P. W.; Stead, P.; Jaxa-Chamiec, A. In Peptides 2000; Martinez, J., Fehrentz, J. A., Eds.; EDK: Paris, France, 2001; pp 271-272.
12. Preliminary results were presented at the 20th American Peptide Symposium, Montreal, Canada. Kulkarni, S. S.; Ross, N. C.; McLaughlin, J. P.; Aldrich, J. V. Adv. Exp. Med. Biol. 2009, 611, 269-270.
13. Schmidt, U.; Langner, J. J. Pept. Res. 1997, 49, 67-73;
14. Davies, J. S. J. Pept. Sci. 2003, 9, 471-501.
15. El Haddadi, M.; Cavelier, F.; Vives, E.; Azmani, A.; Verducci, J.; Martinez, J. J. Pept. Sci. 2000, 6, 560-570;
16. Berst, F.; Ladlow, M.; Holmes, A. B. Chem. Commun. 2002, 508-509.
17. Pastuszak, J.; Gardner, J. H.; Singh, J.; Rich, D. H. J. Org. Chem. 1982, 47, 2982-2987;
18. Schmidt, U.; Beutler, U.; Lieberknecht, A. Angew. Chem., Int. Ed. Engl. 1989, 28, 333-334;
19. Mou, L.; Singh, G. Tetrahedron Lett. 2001, 42, 6603- 6606;
20. Meutermans, W. D.; Bourne, G. T.; Golding, S. W.; Horton, D. A.; Campitelli, M. R.; Craik, D.; Scanlon, M.; Smythe, M. L. Org. Lett. 2003, 5, 2711-2714.
21. Taunton, J.; Collins, J. L.; Schreiber, S. L. J. Am. Chem. Soc. 1996, 118, 10412-10422.
22. Cavelier-Frontin, F.; Pepe, G.; Verducci, J.; Siri, D.; Jacquier, R. J. Am. Chem. Soc. 1992, 114, 8885-8890;
23. Besser, D.; Olender, R.; Rosenfeld, R.; Arad, O.; Reissmann, S. J. Pept. Res. 2000, 56, 337-345.
24. The linear precursors were constructed and minimized using the Tripos force field in SYBYL7.0 (Tripos, Inc., St. Louis, MO). Electrostatic charges were generated using the Gasteiger and Marsili method within SYBYL; an 8Å nonbonded cut-off was employed and a dielectric constant of 4 was applied for minimizations. A three-step minimization protocol, consisting of steepest decent gradient (100 iterations), conjugate gradient (10,000 iterations) and then a BFGS gradient minimization with convergence criterion of 0.001 kcal/ mol, was utilized to obtain convergence.
25. Chan, W. C.; White, P. D. Fmoc Solid Phase Peptide Synthesis: A Practical Approach; Oxford University Press: New York, 2000. pp. 41-76.
26. The yields of cyclic tetrapeptide and cyclic octapeptide measured by HPLC analysis following rapid addition were 28% and 44%, respectively.
27. 4), and the solvent was removed to give the crude cyclic peptide.
28. R = 26.0 min (30-70% aqueous MeOH over 40 min starting after 1 min, flow rate 0.8 mL/min).
29. + = 600.2345 (calcd 600.2587); HPLC: tR = 35.5 min.
30. Albericio, F.; Bofill, J. M.; El-Faham, A.; Kates, S. A. J. Org. Chem. 1998, 63, 9678-9683.
31. Dolle, R. E.; Michaut, M.; Martinez-Teipel, B.; Seida, P. R.; Ajello, C. W.; Muller, A. L.; DeHaven, R. N.; Carroll, P. J. Bioorg. Med. Chem. Lett. 2009, 19, 3647-3650.